
Publication|Articles|November 18, 2026
- November 2026
- Volume 92
- Issue 11
Continuous Glucose Monitoring for Patient Empowerment and Medication Optimization
Author(s)Jeannette Y. Wick, RPh, MBA, FASCP
Fact checked by: Tracy Ann Politowicz
Technology empowers patients and optimizes medication use.
Advertisement
Advertisement
Recent studies are advancing the use of continuous glucose monitoring (CGM) in important ways. Evidence emerging since April 2026 supports its use in adults with type 2 diabetes (T2D) receiving basal insulin and newer medications, strengthens the case for patients who do not use insulin, and brings CGM into pharmacist-led education. Together, these findings give pharmacists more reasons to discuss how glucose patterns can inform everyday choices and medication management.1-3
Related to this article

Safe storage and responsible disposal help protect patients from accidental poisoning and drug misuse while keeping medications stable and effective.

Pharmacists can help identify uncontrolled risk factors, review medications, and reinforce when patients should seek emergency care.

OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.

Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
Advertisement
Advertisement




